Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Antonella Zucchetto|The Journal of Experimental Medicine|2018Cited by 93
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agentsVittorio Emanuele Muccio, Paola Omedè, Elona Saraci et al.|Cytometry Part B Clinical Cytometry|2015Cited by 54
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Eva C. Schitter et al.|Nature Communications|2022Cited by 42